HomeAI · summaries
Storia in 16 fonti
Inside the unconventional FDA panel that could reshape the peptide industry
An unconventional FDA panel is assessing the safety and efficacy of previously-banned peptides. It could open up a multibillion-dollar market.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
wired.com
The Great Peptide Cash Grab Has Begun
The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.
- ·
forbes.com
FDA Set To Review Safety And Access To Peptides: What You Need To Know
An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding pharmacies and the gray market.
